Encompass Health (EHC) EBITDA (2009 - 2026)

Encompass Health (EHC) has reported EBITDA for 18 consecutive years, with $59.7 million the latest figure, recorded in Q1 2026.

• EBITDA for Q1 2026 came in at $59.7 million, down 69.62% year-over-year; the trailing twelve-month figure through Mar 2026 was -$147.2 million (down 122.5% YoY), and the FY2025 annual result was $438.3 million, down 26.53% from the prior year.
• EBITDA was $59.7 million for Q1 2026 at Encompass Health, up from -$415.4 million in the prior quarter.
• Over five years, EBITDA peaked at $196.5 million in Q1 2025 and troughed at -$415.4 million in Q4 2025.
• Average EBITDA over 5 years is $86.2 million, with a median of $113.4 million recorded in 2023.
• Year-over-year, EBITDA soared 149.78% in 2023 and tumbled 352.98% in 2025.
• Over 5 years, EBITDA stood at $184.3 million in 2022, then sank by 52.47% to $87.6 million in 2023, then soared by 87.44% to $164.2 million in 2024, then sank by 352.98% to -$415.4 million in 2025, then jumped by 114.37% to $59.7 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were $59.7 million in Q1 2026, -$415.4 million in Q4 2025, and $12.5 million in Q3 2025.